Clinical Trials · NCT02223416
A Study Aimed at Assessing the Pharmacokinetic Properties of RGB-10 and Forsteo
- Phase
- Phase 1
- Recruitment status
- Completed
- Sponsor
- Gedeon Richter Plc.
- Enrollment
- 0
- Start date
- Not specified
- Locations
- 1 site, United Kingdom
- Primary endpoint
- Area under the plasma concentration versus time curve (AUC)